CD19 and myeloid sarcoma: Significant positive correlations were observed between EBV/VCA-IgG antibody titers and pHERV-Wenv 486-504 cytokine-positive CD19+ B-cells in PP-MS patients (Figure 5A), particularly for IFN-γ and GM-CSF (Figure 5A.1).